Abstract
Assessment of toxicity is an important component of the drug discovery process. Cellbased assays are a popular choice for assessing cytotoxicity. However, these assays are complex because of the wide variety of formats and methods that are available, lack of standardization, confusing terminology and the inherent variability of biological systems and measurement. This review is intended as a guide on how to take these factors into account when planning, conducting and/or interpreting cell based toxicity assays.
Keywords: Cytotoxicity, cytotoxicity screening, viability assays, apoptosis, cell-based assays, toxicity.
Graphical Abstract
Medicinal Chemistry
Title:Cell-based Assays for Assessing Toxicity: A Basic Guide
Volume: 13 Issue: 1
Author(s): Raveen Parboosing, Gugulethu Mzobe, Louis Chonco and Indres Moodley
Affiliation:
Keywords: Cytotoxicity, cytotoxicity screening, viability assays, apoptosis, cell-based assays, toxicity.
Abstract: Assessment of toxicity is an important component of the drug discovery process. Cellbased assays are a popular choice for assessing cytotoxicity. However, these assays are complex because of the wide variety of formats and methods that are available, lack of standardization, confusing terminology and the inherent variability of biological systems and measurement. This review is intended as a guide on how to take these factors into account when planning, conducting and/or interpreting cell based toxicity assays.
Export Options
About this article
Cite this article as:
Parboosing Raveen, Mzobe Gugulethu, Chonco Louis and Moodley Indres, Cell-based Assays for Assessing Toxicity: A Basic Guide, Medicinal Chemistry 2017; 13 (1) . https://dx.doi.org/10.2174/1573406412666160229150803
DOI https://dx.doi.org/10.2174/1573406412666160229150803 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Diagnostic Utility of Pleural Fluid Tests in Clinical Practice
Current Respiratory Medicine Reviews Engineered Silver Nanoparticles, A New Nanoweapon Against Cancer
Anti-Cancer Agents in Medicinal Chemistry Small Molecule Toxins Targeting Tumor Receptors
Current Pharmaceutical Design Functional Nanogels for Biomedical Applications
Current Medicinal Chemistry Modulation of Photosensitization Processes for an Improved Targeted Photodynamic Therapy
Current Medicinal Chemistry The Epigenetic Origin of Aneuploidy
Current Genomics Recent Advances of Chitosan and its Derivatives in Biomedical Applications
Current Medicinal Chemistry Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
Current Cancer Drug Targets Current State of ERG as Biomarker in Prostatic Adenocarcinoma
Current Cancer Drug Targets A Novel Fluorescence-Labeled Curcumin Conjugate: Synthesis, Evaluation and Imaging on Human Cell Lines
Current Pharmaceutical Design Current Trends in the Application of Nanoparticles in Drug Delivery
Current Medicinal Chemistry Overview of the Formulations and Analogs in the Taxanes' Story
Current Medicinal Chemistry A Review on Missing Value Imputation Algorithms for Microarray Gene Expression Data
Current Bioinformatics Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents
Current Drug Targets Post-Translational Protein Modifications of Rare and Unconventional Types: Implications in Functions and Diseases
Current Medicinal Chemistry Prospects for Plant-Derived Chemopreventive Agents Exhibiting Multiple Mechanisms of Action
Current Medicinal Chemistry - Anti-Cancer Agents Molecular Targets for Epigenetic Therapy of Cancer
Current Pharmaceutical Biotechnology Breast Cancer Biomarkers: Risk Assessment, Diagnosis, Prognosis, Prediction of Treatment Efficacy and Toxicity, and Recurrence
Current Pharmaceutical Design Targeting the Multifaceted HuR Protein, Benefits and Caveats
Current Drug Targets Natural DNA Intercalators as Promising Therapeutics for Cancer and Infectious Diseases
Current Cancer Drug Targets